Search

Embecta Corp

Closed

SectorHealthcare

6.45 0.47

Overview

Share price change

24h

Current

Min

6.36

Max

6.45

Key metrics

By Trading Economics

Income

25M

21M

Sales

50M

272M

P/E

Sector Avg

4.361

68.089

EPS

0.56

Dividend yield

7.43

Profit margin

7.766

Employees

1,850

EBITDA

20M

65M

Dividends

By Acuity

Dividend yield

Sector Avg

7.43%

1.98%

Next Earnings

24 lis 2026

Next Dividend date

17 gru 2026

Next Ex Dividend date

4 gru 2026

Market Stats

By TradingEconomics

Market Cap

142M

363M

Previous open

5.98

Previous close

6.45

Embecta Corp Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

13 lis 2026, 22:41 UTC

Embecta Corp. is trading lower in after-market hours, reflecting broader market declines driven by Federal Reserve rate hike concerns and turmoil in the tech sector.

12 lis 2026, 21:02 UTC

News

Embecta Corp. is under investigation by Bronstein, Gewirtz & Grossman, LLC for potential corporate wrongdoing involving the company and its officers or directors.

11 lis 2026, 21:06 UTC

Embecta Corp. shares are trading higher, recovering from early lows to peak around midday, remaining above the 20-day moving average.

10 lis 2026, 20:46 UTC

News

Embecta Corp. is under investigation by Bronstein, Gewirtz & Grossman, LLC for potential corporate wrongdoing involving its officers and directors.

9 lis 2026, 23:31 UTC

Embecta Corp. is seeing a deeper decline in after-market trading, moving further below its 20-day moving average by session's end.

6 lis 2026, 21:07 UTC

Embecta Corp. shares fell sharply, continuing a decline from Thursday's close and remaining below the 20-day moving average.

5 lis 2026, 21:08 UTC

News

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Embecta Corp. over allegations of corporate wrongdoing involving its officers and directors.

4 lis 2026, 21:04 UTC

Embecta Corp. shares are sharply higher, marking a significant increase since Tuesday's close, despite broader market volatility earlier in the day.

3 lis 2026, 20:36 UTC

News

Embecta Corp. is under investigation by Bronstein, Gewirtz & Grossman, LLC, regarding potential corporate misconduct involving the company and its officers or directors.

2 lis 2026, 20:36 UTC

Embecta Corp. shares fell below Friday's close, fluctuating earlier in the session before retreating to the middle of its one-month range.

30 paź 2026, 20:03 UTC

Embecta Corp. shares fell sharply, facing significant selling pressure and reaching a cumulative return of approximately -4.73% since Thursday's close.

29 paź 2026, 20:02 UTC

Embecta Corp. shares are advancing notably during Thursday's session, currently positioned above its 20-day moving average and near the upper end of its one-month range.

27 paź 2026, 20:02 UTC

News

Embecta Corp. is under investigation by Bronstein, Gewirtz & Grossman, LLC for potential corporate wrongdoing claims involving its officers and directors.

26 paź 2026, 20:21 UTC

Embecta Corp shares declined modestly in after-market trading, falling from Monday's close and reaching the day's lowest point after a brief pause.

22 paź 2026, 20:04 UTC

Embecta Corp shares are notably higher, having pulled back from an earlier peak, but remain up compared to Wednesday's close amid strong recent performance.

21 paź 2026, 20:07 UTC

Embecta Corp shares are advancing, continuing a trend of gains since Tuesday's close, aligning with a broader market increase and positioned above its 20-day moving average.

20 paź 2026, 20:08 UTC

Embecta Corp shares are advancing, maintaining a position above their 20-day moving average amid a strong session for the health care supplies sector.

15 paź 2026, 20:02 UTC

Embecta Corp shares are trading sharply higher, continuing a strong performance and remaining near the upper end of their one-month range.

14 paź 2026, 19:46 UTC

Embecta Corp shares fell, reflecting a cumulative decline while remaining above its 20-day moving average and near the upper end of its one-month range.

13 paź 2026, 20:13 UTC

Embecta Corp's shares declined during after-market hours on Tuesday, maintaining a loss since the regular session close.

12 paź 2026, 23:06 UTC

Embecta Corp's shares advanced modestly higher in after-market trading, recovering from a low point earlier in the session while remaining above its 20-day moving average.

9 paź 2026, 19:35 UTC

Embecta Corp's shares are roughly flat, showing little change since Thursday's close, while positioned above its 20-day moving average.

8 paź 2026, 20:07 UTC

News

Embecta Corp is under investigation by Bronstein, Gewirtz & Grossman, LLC, regarding potential corporate wrongdoing involving its officers and directors.

7 paź 2026, 20:08 UTC

Embecta Corp shares fell modestly, retracing from a peak earlier in the day, but remain above their 20-day moving average.

6 paź 2026, 19:20 UTC

Embecta Corp is trading higher, supported by broader market gains and positive economic indicators, despite earlier pulling back from a session high.

5 paź 2026, 22:31 UTC

Embecta Corp is experiencing downward pressure in after-market trading, with losses accelerating since Monday's close while remaining above its 20-day moving average.

2 paź 2026, 23:20 UTC

Embecta Corp is seeing a notable decline in after-market trading, reaching its lowest cumulative return since Friday's close.

1 paź 2026, 20:07 UTC

Embecta Corp is advancing, remaining well above its previous close and significantly above its 20-day moving average, despite a slight pullback earlier in the session.

30 wrz 2026, 20:02 UTC

Embecta Corp shares fell sharply after an early high, continuing a decline since Tuesday's close while remaining above the 20-day moving average.

29 wrz 2026, 20:07 UTC

News

Embecta Corp shares are declining as Bronstein, Gewirtz & Grossman, LLC announced an investigation into potential corporate wrongdoing by the company's officers and directors.

Peer Comparison

Price change

Embecta Corp Forecast

Rating Consensus

By TipRanks

Neutral

1 ratings

0

Buy

1

Hold

0

Sell

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Embecta Corp

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
help-icon Live chat